HON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Honeywell (HON) is a good buy right now for a beginner long-term investor with $50,000-$100,000 available. My direct view: buy it now. The stock has strong Wall Street support, positive catalyst momentum from the post-spin re-rating, and unusually bullish options sentiment. Even though the chart is technically weak in the very short term, the long-term setup is favorable and the current price is still supported by analyst targets. For an impatient buyer who does not want to wait for a perfect entry, HON is acceptable to buy now as a long-term position.
HON is in a short-term downtrend despite the recent move, with MACD histogram at -27.416 and still negatively expanding, which confirms bearish momentum. RSI_6 at 12.391 shows the stock is deeply oversold, so near-term downside may be limited and a bounce is possible. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, so the trend has not fully reversed yet. Price at 229.94 is below the nearest resistance zone and well above the stated S1 support of 255.258? The provided support/resistance levels appear inconsistent with the current price, so I place more weight on the trend indicators: short-term momentum is weak, but the stock looks stretched to the downside and likely close to a rebound zone.
["Multiple analysts recently raised price targets and maintained Buy/Outperform ratings.", "Daiwa upgraded HON to Outperform after the aerospace spin-off, citing a more focused portfolio and solid earnings growth potential.", "Citi and Deutsche Bank both raised targets, showing improving Street confidence.", "The spin-off of the aerospace business should improve Honeywell's focus and earnings quality.", "Congress trading data shows 1 purchase and 0 sales in the past 90 days, a positive signal.", "Options positioning is bullish with a low put-call open interest ratio.", "Long-term thematic support from industrial automation and margin expansion."]
["Technical trend remains bearish in the short term with MACD still weakening.", "RSI is extremely oversold, which reflects weakness rather than strength.", "Recent analyst target changes are mixed, with some cuts earlier in the period and Jefferies holding a Neutral/Hold view.", "News flow in the feed is mostly about other companies, so there is no strong company-specific near-term news catalyst beyond the spin-off story.", "Hedge funds and insiders are both neutral, showing no strong insider accumulation trend."]
No valid latest-quarter financial snapshot was provided because the financial snapshot returned an error. Based on the analyst commentary, the market appears to expect better sales consistency and margin expansion after the spin-off, but I cannot confirm quarterly growth from the supplied financial data. The latest quarter season is not available in the dataset.
Street sentiment is positive overall. Recent actions include Citi lowering its target slightly to $260 while keeping Buy, Deutsche Bank raising to $263 and keeping Buy, Daiwa upgrading to Outperform with a $255 target, RBC raising to $275 with Outperform, Goldman Sachs raising to $276 with Buy, and Barclays maintaining Overweight with a $251 target. The overall analyst trend is constructive: targets have generally been raised, and the post-spin Honeywell is being viewed as a more focused automation company with better earnings leverage. Wall Street pros see clearer growth, margin expansion, and value creation from the restructuring. The main con is that some firms still see limited near-term upside versus earlier expectations and at least one firm remains Hold/Neutral.
